Found: 11
Select item for more details and to access through your institution.
In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs.
- Published in:
- Mycoses, 2023, v. 66, n. 3, p. 258, doi. 10.1111/myc.13550
- By:
- Publication type:
- Article
Dermatology mycology diagnostics in Ireland: National deficits identified in 2022 that are relevant internationally.
- Published in:
- Mycoses, 2023, v. 66, n. 3, p. 249, doi. 10.1111/myc.13549
- By:
- Publication type:
- Article
Effect of coccidioidomycosis prophylaxis in selecting non‐Candida albicans species amongst solid organ transplant recipients in Arizona.
- Published in:
- Mycoses, 2023, v. 66, n. 3, p. 237, doi. 10.1111/myc.13547
- By:
- Publication type:
- Article
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato.
- Published in:
- Mycoses, 2023, v. 66, n. 3, p. 196, doi. 10.1111/myc.13541
- By:
- Publication type:
- Article
Perturbations of immune landscape in COVID‐19 associated mucormycosis.
- Published in:
- Mycoses, 2023, v. 66, n. 3, p. 226, doi. 10.1111/myc.13546
- By:
- Publication type:
- Article
Dihydroorotate dehydrogenase inhibitor olorofim has potent in vitro activity against Microascus/Scopulariopsis, Rasamsonia, Penicillium and Talaromyces species.
- Published in:
- Mycoses, 2023, v. 66, n. 3, p. 242, doi. 10.1111/myc.13548
- By:
- Publication type:
- Article
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture.
- Published in:
- Mycoses, 2023, v. 66, n. 3, p. 219, doi. 10.1111/myc.13545
- By:
- Publication type:
- Article
Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases.
- Published in:
- Mycoses, 2023, v. 66, n. 3, p. 181, doi. 10.1111/myc.13538
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of invasive and non‐invasive fusariosis in South Korea.
- Published in:
- Mycoses, 2023, v. 66, n. 3, p. 211, doi. 10.1111/myc.13544
- By:
- Publication type:
- Article
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis.
- Published in:
- Mycoses, 2023, v. 66, n. 3, p. 202, doi. 10.1111/myc.13542
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Mycoses, 2023, v. 66, n. 3, p. 177, doi. 10.1111/myc.13455
- Publication type:
- Article